Pelage Pharmaceuticals, based in Los Angeles, has announced the commencement of its Phase 2a clinical trial for a groundbreaking treatment targeting androgenetic alopecia,...
ByYoung By ChoiceAugust 23, 2024Mayo Clinic's latest AI research illuminates the brain’s concealed patterns, offering a groundbreaking approach to detecting early signs of dementia. By analyzing neural...
ByYoung By ChoiceAugust 1, 2024In a groundbreaking study, scientists are delving deeper than ever into the true mechanisms of antidepressants. Moving beyond the serotonin theory, they’re uncovering...
ByYoung By ChoiceJune 22, 2024